MC1R: Melanocyte-stimulating hormone receptor
A drug works by acting on something in the body, usually a protein made by one gene. This is a page for each of those targets: the drugs that hit it and the diseases it is tied to.
G protein-coupled receptor that binds melanocyte-stimulating hormones (alpha, beta, and gamma-MSH) and adrenocorticotropic hormone/ACTH, which are peptide products of the POMC precursor protein.
- Drugs that act on it: 3
- With a US drug page: 1
- Type: Protein
Drugs That Act on It
Approved and clinical-stage drugs ChEMBL records for this target; those with a US drug page link to it. All act as: Melanocortin receptor 1 agonist.| Afamelanotide | Approved | — | Agonist | — |
| Dersimelagon | — | — | Agonist | — |
| Modimelanotide | — | — | Agonist | — |
Diseases Most Associated With It
Open Targets association score, 0 to 1; all associations- Abnormal skin pigmentation
- 0.73
- Skin neoplasm
- 0.63
- Skin cancer
- 0.60
- Melanoma
- 0.59
- Vitiligo
- 0.58
- Basal cell carcinoma
- 0.57
- Hair color
- 0.57
- Skin disorder
- 0.57
- Erythropoietic protoporphyria
- 0.56
- Neoplasm
- 0.55
Drugs and mechanisms are from ChEMBL CHEMBL3795 (CC BY-SA 3.0). Gene name, function (UniProt Q01726, CC BY 4.0) and disease associations are from Open Targets (CC0). ChEMBL and Open Targets